Facultade de Enfermaría
Facultad
University of California, San Francisco
San Francisco, Estados UnidosPublicacións en colaboración con investigadores/as de University of California, San Francisco (12)
2020
-
Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States
Transplantation, Vol. 104, Núm. 10, pp. 2078-2086
2018
-
Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series
Clinical Transplantation, Vol. 32, Núm. 7
-
Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient
Transplant Infectious Disease, Vol. 20, Núm. 1
2017
-
New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality
Pediatric Critical Care Medicine, Vol. 18, Núm. 1, pp. 8-16
2016
-
Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability
Critical Care Medicine, Vol. 44, Núm. 12, pp. 2241-2250
-
Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs
Pediatric Critical Care Medicine, Vol. 17, Núm. 6, pp. 522-530
-
Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus
Clinical Transplantation, Vol. 30, Núm. 9, pp. 1140-1145
-
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy
Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 12, pp. 1319-1329
2015
-
Advances in therapy for HIV/Hepatitis C virus-coinfected patients in the liver transplant setting
Clinical Infectious Diseases, Vol. 60, Núm. 1, pp. 108-116
-
Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study
Critical Care, Vol. 19, Núm. 1
-
Hepatitis C genotype influences post-liver transplant outcomes
Transplantation, Vol. 99, Núm. 4, pp. 835-840
-
Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients
Liver Transplantation